Increasingly, PDAs are becoming a critical tool for physicians. For example, according to a Manhattan Research report, the penetration rate is over 50% -- which compares to 30% in 2001. There are certainly major benefits, such as patient safety, compliance, and improved productivity.
One of the top operators in the space is Epocrates. And the company has recently filed to go public.
Basically, Epocrates has a huge database of clinical information and decision support systems that are delivered wirelessly. Just some of the information includes: dosing, pricing, insurance coverage, and disease diagnostics. The subscriber base is in excess of 500,000.
Should you sell into today's rally? Yes, if you think there are more surprises to come (I do)
The week in preview: Mulling over techs, financials
'Crash-and-burn economy?' 'Bailout beer bust?' What should we call America's economic disaster?
